-
News | 2021.02.15
Discovery of messenger RNA in 1961
Since the beginning of the COVID-19 pandemic, words that just a year ago would have been the preserve of scientists have entered everyday language. One example is PCR, used for diagnostic tests. Another term that was once unfamiliar and is now on everyone's lips is messenger RNA, the miraculous molecule that has led to vaccines being administered to the general population less than a year after...
-
News | 2021.03.11
2019-2023 Strategic Plan: Two new projects to boost the Institut Pasteur Innovation Accelerator
Two projects have been accepted into the Institut Pasteur Innovation Accelerator, an initiative to improve the development potential of the Institut Pasteur's research: a highly automated technological system involving bioassays and a partnership based on a French startup studio. The Institut Pasteur will be setting up the project Pfbioassays [in French] (Thierry Rose and Sébastien...
-
Article | 2021.10.18
Monod Class (2010-2013)
Ph.D. StudentUndergraduate studiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. projectMichael Jason BLANDValdosta State University, Georgia, USABacterial Genome PlasticityDidier MazelDidier MazelCdVStudy of the constraints sustaining the 2 chromosomes structuring in Vibrio choleraeAndreas KUHBACHERETH Zurich, SwitzerlandBacteria and Cell InteractionsJavier Pizarro-CerdaPascale...
-
News | 2022.09.05
COVID-19: we are looking for volunteers to improve our understanding of immunity
We are looking for volunteers to take part in the CORSER-5 study. The study was launched in March 2022 to compare the immunity of COVID-19-positive individuals at the very beginning of their infection period ("cases") with that of non-infected individuals ("controls"). The results could be used to establish a booster vaccination strategy for SARS-CoV-2 on the basis of patients' antibody...
-
News | 2022.11.17
Royal Society: looking back at the tribute to Louis Pasteur in London
The Institut Pasteur, the French Academy of Sciences and the Royal Society held a scientific symposium that brought French and British researchers together to celebrate the bicentenary of Louis Pasteur's birth and promote international scientific cooperation.
-
News | 2022.12.07
SpikImm receives a major funding to accelerate the clinical and industrial development of its monoclonal antibodies against SARS-CoV-2
SpikImm, a biotech company founded in 2021 by Truffle Capital in collaboration with the Institut Pasteur, has been awarded a €15 million non-dilutive financing from the French governmentFrance 2030 program for its "PROPHYMAB" project, which is supported as part of the "Emerging Infectious Diseases and CBRN Threats" Acceleration Strategy. SPK001, the first treatment candidate (...
-
Fiche maladie | 2022.01.11
Chlamydia
Chlamydia is a sexually transmitted infection (STI) caused by the bacterium Chlamydia trachomatis. It is the most widespread bacterial STI, affecting both men and women, and is particularly common among young people. In many cases, infection is asymptomatic and is therefore not diagnosed or treated, which contributes to its spread. Chlamydia can be contracted several times, since acquired...
-
News | 2023.05.04
Chikungunya: how the tiger mosquito helps the virus cross borders
The tiger mosquito, which is native to Southeast Asia, is set to continue to spread to temperate regions and pose a major public health problem. Researchers at the Institut Pasteur have shown that this mosquito has acquired the ability to transmit the chikungunya virus as effectively at 20°C as at 28°C.
-
Portrait | 2023.02.10
Caroline Demangel – an ambitious and enterprising scientist
Finding her path, making meaningful choices and daring to take the initiative – these are the principles that have guided Caroline Demangel through her career. In the demanding and competitive field of science, she has trusted her aspirations and risen to new challenges. In 2021, the scientist and her team revealed a new therapeutic target for bone marrow cancer.
-
Article | 2019.06.25
Pathogen genomics and microbiota (8 entities)
Research in this thematic area explores the genomes of infectious agents in relation with their evolution. It also investigates the regulation of the microbiota composition and the mechanisms by which microbiota dysbiosis influences antimicrobial immunity.